Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

Inhibition of Group IVA Cytosolic Phospholipase A2 by Thiazolyl Ketones in Vitro, ex Vivo, and in Vivo

(2014) George Kokotos et al.   JOURNAL OF MEDICINAL CHEMISTRY

Vessel calibre—a potential MRI biomarker of tumour response in clinical trials

(2014) Kyrre E. Emblem et al.   Nature Reviews Clinical Oncology

Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts

(2013) Siver A. Moestue et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Cytosolic PhospholipaseA2 Inhibition with PLA-695 Radiosensitizes Tumors in Lung Cancer Animal Models

(2013) Dinesh Thotala et al.   PLoS One

Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer

(2012) Qingchun Cai et al.   FASEB JOURNAL

Assessing breast cancer angiogenesis in vivo: which susceptibility contrast MRI biomarkers are relevant?

(2012) Eugene Kim et al.   MAGNETIC RESONANCE IN MEDICINE

Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts

(2012) Evita M. Lindholm et al.   Molecular Oncology

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis

(2012) Z-H Wen et al.   ONCOGENE

Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises

(2011) Annika Armulik et al.   DEVELOPMENTAL CELL

In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts

(2011) Else M. Huuse et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

(2011) Peter Carmeliet et al.   NATURE REVIEWS DRUG DISCOVERY

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

(2011) Shom Goel et al.   PHYSIOLOGICAL REVIEWS

COX-2 and PGE2-dependent immunomodulation in breast cancer

(2011) Edward P. Chen et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis

(2010) A. G. Linkous et al.   JNCI-Journal of the National Cancer Institute

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

(2009) A. Greenhough et al.   CARCINOGENESIS

Cytosolic Phospholipase A2: Targeting Cancer through the Tumor Vasculature

(2009) A. Linkous et al.   CLINICAL CANCER RESEARCH

Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology

(2009) L. M. Ellis et al.   CLINICAL CANCER RESEARCH

Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models

(2009) Anna Bergamaschi et al.   Molecular Oncology

Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium

(2008) E M Yazlovitskaya et al.   CELL DEATH AND DIFFERENTIATION

Tumor Vascular Maturation and Improved Drug Delivery Induced by Methylselenocysteine Leads to Therapeutic Synergy with Anticancer Drugs

(2008) A. Bhattacharya et al.   CLINICAL CANCER RESEARCH

Cytosolic Phospholipase A2- : A Potential Therapeutic Target for Prostate Cancer

(2008) M. I. Patel et al.   CLINICAL CANCER RESEARCH

How basal are triple-negative breast cancers?

(2008) François Bertucci et al.   INTERNATIONAL JOURNAL OF CANCER

Assessment of PLSDA cross validation

(2008) Johan A. Westerhuis et al.   Metabolomics